Mino-Wrap (CITI-101) is a malleable, bio-absorbable film impregnated with minocycline and
rifampin. It is a novel therapeutic designed to significantly reduce infections associated with the
use of breast tissue expanders (TE) used in patients that elect to undergo reconstructive breast
surgery. Mino-Wrap is in the pre-clinical stage. The results of our pre-clinical studies will determine whether we seek regulatory approval for Mino-Wrap.
Program Highlights
- Potential to be first and only FDA-approved product to prevent infections associated
with post mastectomy breast implants
- Currently in pre-clinical development
- Development in partnership with The University of Texas MD Anderson Cancer Center
and support from medical thought leaders